State Ledger
Company profile

DiaMedica Therapeutics Inc. CIK 1401040

Ticker
DMAC (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Minneapolis, MN 55305
Fiscal year end
2025 (FY)
Market Data
Close
$7.82
Change
-$0.40
Change %
-4.87%
Volume
10,867

DMAC · trading date Oct 13, 2026 · previous close $8.22 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$32.77M
Total assets
$61.37M
Total liabilities
—
Stockholders' equity
$56.11M
Cash & equivalents
$15.65M
Operating income
-$34.40M
Operating cash flow
-$29.06M
Capital expenditures
$40.0K

Fiscal year 2025, via 10-K filed 2026-03-30. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$29.10M
Free cash flow margin
—
Liabilities / assets
—
Equity / assets
91.4%
CapEx / revenue
—
Operating cash flow / net income
0.89×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$32.77M $61.37M — $56.11M
2024 — -$24.44M $46.35M — $40.72M
2023 — -$19.38M $54.16M — $51.06M
2022 — -$13.68M $34.40M — $31.83M
2021 — -$13.59M $45.55M — $44.02M
Company Details
SIC code
2834
State of incorporation
Z4
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-12
Financials filed via
Form 10-K
filed 2026-03-30

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Minneapolis, MN 55305
301 CARLSON PARKWAY
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:36 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Minnesota — Public Companies